James R. Empfield, SVP, Drug Discovery at Xenon Pharmaceuticals Inc. (XENE), bought 10,000 shares at $2.48 ($25K) on 2017-08-15, disclosed to the SEC on 2017-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |